Innovation Pharmaceuticals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Leo Ehrlich
Chief executive officer
US$515.9k
Total compensation
| CEO salary percentage | 90.3% |
| CEO tenure | 17.4yrs |
| CEO ownership | 1.3% |
| Management average tenure | no data |
| Board average tenure | 8.7yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | US$516k | US$466k | -US$3m |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | n/a | n/a | -US$5m |
| Sep 30 2022 | n/a | n/a | -US$6m |
| Jun 30 2022 | US$906k | US$466k | -US$7m |
| Mar 31 2022 | n/a | n/a | -US$8m |
| Dec 31 2021 | n/a | n/a | -US$10m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | US$516k | US$466k | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$13m |
| Dec 31 2020 | n/a | n/a | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$6m |
| Jun 30 2020 | US$545k | US$466k | -US$7m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | n/a | n/a | -US$7m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | US$466k | US$466k | -US$9m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | n/a | n/a | -US$13m |
| Sep 30 2018 | n/a | n/a | -US$14m |
| Jun 30 2018 | US$466k | US$466k | -US$16m |
Compensation vs Market: Leo's total compensation ($USD515.85K) is about average for companies of similar size in the US market ($USD650.80K).
Compensation vs Earnings: Leo's compensation has been consistent with company performance over the past year.
CEO
Leo Ehrlich (66 yo)
17.4yrs
Tenure
US$515,850
Compensation
Mr. Leo Ehrlich, CPA serves as Chairman at Innovation Pharmaceuticals Inc. He has been the Chief Executive Officer and Chief Financial Officer of Innovation Pharmaceuticals Inc. (previously known as Cellce...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 17yrs | US$515.85k | 1.34% $ 1.4k | |
| Scientific Advisor of Drug Discovery & Clinical Development | 4.3yrs | no data | no data | |
| Scientific Advisor of Oral Mucositis & Member of the Advisory Board | 8.7yrs | no data | no data | |
| Scientific Advisor of Gastroenterology & Member of the Advisory Board | no data | no data | no data | |
| Scientific Advisor of Intellectual Property | 13.6yrs | no data | no data | |
| Scientific Advisor of Mycology & Fungal Diseases and Member of the Advisory Board | 1.6yrs | no data | no data |
8.7yrs
Average Tenure
Experienced Board: IPIX's board of directors are considered experienced (8.7 years average tenure).